[4] It is important to distinguish pancreatitis from the common gastrointestinal side effects that affect many semaglutide users, particularly during dose escalation
Diarrhea, vomiting, and constipation vary between patients: GI motility changes are a class effect across GLP-1 drugs and retatrutide produces them at a rate consistent with that, with different patients experiencing different patterns depending on their gut baseline and how quickly the dose moves up
There are various ways to lower your TMAO levels, such as eating more vegetables, dietary fiber, probiotic and resveratrol-rich foods [92, 93, 94]
Data interpretation is difficult because the observed modifications in hyperhomocysteinemic subjects may merely result from the occurrence of cardiovascular disorders
Malhotra, R., Singh, L., Eng, J